Article Sidebar

PDF
Date Published: 12/06/2021
Abstract Views: 130
Views PDF: 169
DOI: https://doi.org/10.51298/vmj.v500i2.372
Issue
Vol. 500 No. 2 (2021)
Section
Các bài báo
How to Cite
Thị Huyền, P. . (2021). EVALUATION OF EFFECTIVE CHEMORADIATION THERAPY IN TREATMENT IN NON SMALL CELL LUNG CANCER STAGE IIIB IN K HOSPITAL. Vietnam Medical Journal, 500(2). https://doi.org/10.51298/vmj.v500i2.372

EVALUATION OF EFFECTIVE CHEMORADIATION THERAPY IN TREATMENT IN NON SMALL CELL LUNG CANCER STAGE IIIB IN K HOSPITAL

Phùng Thị Huyền

Main Article Content

Abstract

Purpose: To analyze the relationship between the dose and the effect treatment of concomitant chemotherapy in stage IIIb non-small cell lung cancer at K Hospital. Materials and methods: A prospective study describes 70 patients with stage IIIb non-small cell lung cancer receiving chemotherapy with concomitant paclitaxel-carboplatin and accelerated radiotherapy. Results: Patients who received enough chemoradiation had higher efficacy than those who did not receive enough. Conclusion: Sufficient treatment is recommended, if not enough, radiotherapy should be given priority.

Article Details

Keywords

lung cancer, non-small cell, concurrent chemotherapy

References

1. Cancer International Agency for Research on (2012). GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012.
2. Okawara Gordon, Mackay Jean A, Evans William K, et al. (2006). Management of unresected stage III non-small cell lung cancer: a systematic review. Journal of Thoracic Oncology, 1(4), 377-393.
3. Belani Chandra P, Choy Hak, Bonomi Phil, et al. (2005). Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non–small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. Journal of clinical oncology, 23(25), 5883-5891.
4. Choy H, Akerley W, Safran H, et al. (1998). Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Journal of clinical oncology, 16(10), 3316-3322.
5. Schiller Joan H, Harrington David, Belani Chandra P, et al. (2002). Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer. New England Journal of Medicine, 346(2), 92-98.
6. Bradley JD, Paulus R, Komaki R, et al. (2011). A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy+/-cetuximab for stage IIIA/IIIB non-small cell lung cancer: preliminary findings on radiation dose in RTOG 0617. 53rd annual meeting of the American Society of Radiation Oncology, 2-6.